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Abstract
Nearly 80 years ago, scientist Otto Warburg originated a hypothesis that the cause of cancer is primarily a defect in
energy metabolism. Following studies showed that mitochondria impact carcinogenesis to remodel somatic cells
to cancer cells through modifying the genome, through maintenance the tumorigenic phenotype, and through
apoptosis. And the Endosymbiotic Theory explains the origin of mitochondria and eukaryotes, on the other hands,
the mitochondria also can fall back. Compared to chromosome genomes, the mitochondria genomes were not
restricted by introns so they were mutated(fall back) easy. The result is that mitochondria lose function and internal
environment of somatic cell become acid and evoked chromosome genomes to mutate, in the end somatic cells
become cancer cells. It is the trigger of somatic cell transforming to cancer cell that mitochondria genome happen
mutation and lose function.
Cancer energy metabolism and mitochondria
Nearly 80 years ago, scientist Otto Warburg observed
that cancer cells perform energy metabolism in a way
that is different from normal adult cells, so he originated
a hypothesis that the cause of cancer is primarily a
defect in energy metabolism [1]. With the mutational
theory of carcinogenesis(including oncogenes and tumor
suppressor genes) discovering, Warburg’ theory has
expressed shortage, but mitochondria engageing process
of carcinogenesis become to highlight, Cavalli suggest
that mitochondria impact carcinogenesis through mito-
chondrial DNA acting as transposable elements and
modifying the genome, through mitochondrial mainte-
nance of the tumorigenic phenotype, and through the
role of mitochondria in apoptosis [2].
Cause of modification in glycolysis
Since the days of Warburg, studies have continued to
show alterations of functional energy metabolism in
cancer cells. The cancer cells look like to be function
losed cells and only energy consuming cells, they survive
just for surviving and proliferating. Among these differ-
ences are increased rate of glycolysis [3], and shifts in
LDH isozyme patterns [4], and ceased production of
functional proteins [5]. The high glycolysic rate
maintained by proliferating cells and tumor cells may
possibly be due to altered expression of enzymes [6].
Glycolysis may be stimulated by availability of ADP(a
rate-limiting step), and it has been suggested that either
inefficient ATPase activity(the Na+/K+ atpAse in Ehrlich
ascites tumor cells) leading to increased ATP hydrolysis
[7] or increased ATPase activity may contributed to the
increased ADP levels [8]. In effect, the cancer cell
almost stop using the citric acid cycle to get energy.
Traditional theory on mutution of mitochondrial
genome
In terms of the mitochondrial genome, there is some
evidence for the transfer of mitochondrial DNA into the
nuclear genome, even in the human cell [9]. There ie
also abundant evidence for alteration of transcription
rates for the mitochondrial genome in cancer cells [10].
Mitochondrial DNA may also be more susceptible to
mutution [11]. This may be due either to its supercoiler
struture [12] or the paucity of repair mechanism for
Mitochondrial DNA [13]. Another contributing factor
may be the relatively constant exposure of Mitochon-
drial DNA to free radicals produced by the respiratory
chain. Finally, study of hamster kidney tumor cells indi-
cated that there is a reduction in Mitochondrial DNA in
those cells, which may have implications for functional
energy metabolism in those cells [14]. Above all, there* Correspondence: djppk@163.com
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may be another reason why mitochondrial genome easly
mutate, that is from Endosymbiotic Theory.
Endosymbiotic Theory
In the 1960’s, Lynn Margulis found that their many
similarities between prokaryotic cells and the organelles
of eukaryotic cells and established hypothesis officially
in her 1981 book “Symbiosis in Cell Evolution”. The
theory maintains that ancestors of eukaryotic cells were
“symbiotic consortiums” of prokaryote cells with at least
one and possibly more species (endosymbionts)
involved. In other words, perhaps oxygen breathing bac-
teria(mitochondria) invaded an anareobic amoebalike
bacteria(original prokaryotic host cell), and each per-
formed mutually benefiting functions. The bacteria
would breathe for the anareobic amoebalike bacteria,
and the amoebalike bacteria would navigate through
new oxygen-rich waters in search of food. This way,
each of the organisms would be benefiting from their
symbiotic relationship as the waters and atmosphere of
the Precambrian changed. The invaded bacteria were
mitochondria [15], then random mutations in the form
of deletions large and small seem to have eliminated
nonessential genes from the endosymbiont-mitochon-
drial genome lineages [16]. But mitochondria genomes
consist of a single circular molecule of DNA and have
their own protein-synthesizing machinery.
Reason mitochondrial genome mutation
From Endosymbiotic Theory, human normal cell and
mitochondrial have a relative genomes and protein-
synthesizing system [17], they work independently and
live together harmony. And each human cell contains
hundreds of mitochondrion and each mitochondrion
contains several presumably identical circular DNA
molecules, frequently, a tumor will contain identical
mitochondrial mutations [18]. Why? Paula suggests that
tumor-associated mtDNA mutations lead to increased
production of reactive oxygen species (ROS), a by-pro-
duct of mitochondrial oxidative phosphorylation, which
can stimulate cell proliferation [19]. I hypothesis that
contrary to chromosome genomes, mitochondrial gen-
ome lack introns, so missed introns result in mitochon-
drial genome vulnerable to be affected by malignant
envirments, such as free radicals(reactive oxygen spe-
cies), especially maybe the introns look like housekeep-
ing genes? Without introns maintenance genomes
stable, the mitochondrial DNA may be more susceptible
to mutution with no introns. Above all, the mutation of
mitochondrial genomes is easier than somatic cell gen-
omes. In fact, mutations in mtDNA have been identified
in various types of human cancer, such as Breast cancer,
Ovary cancer, Colon cancer, et al [20].
Questions need answer
It is certain that cancer cell contains mutation genes of
chromosomes, and mutations in mtDNA also identified in
cancer cell. For why these mutation happened, there are
many hypotheses about the origin of cancer, from Otto
Warburg’s to Paula A.Kiberstis’s, their focas is still on
energy metabolism and relevant mechanisms. Still now,
important questions to be addressed include (1) What is
the exact role of mtDNA in cancer initiation and progres-
sion? (2) How do heteroplasmic mtDNA mutations arise
and evolve to a homoplasmic state in cancer cells? (3) Is
there a mechanistic link between mtDNA mutations,
changes in respiration and ROS generation, and alterations
in apoptosis? [21] The answers to these questions would
undoubtedly advance our understanding of mitochondrial
biology in cancer, but no man exactly knows. Tumorigen-
esis is a complex process involving the activation of
oncognens, inactivation of tumor suppressors and deregu-
lation. The findings that pro-apoptotic genes might act as
tumor suppressors and anti-apoptotic genes can serve as
oncogenes suggested that the balance between pro-apop-
totic and anti-apoptotic modulates tumor growth [22].
What exactly happened firstly remain pondering when a
somatic cell transform to cancer cell?
My hypothesis
Mitochondrial DNA mutations have been observed in
many types of human cancer [23]. The reason why
mtDNA is easily mutate when they copy that they
lack introns. And all mutation mtDNA are tumor-asso-
ciated mtDNA. As Petron’s experiment describes, the
pathogenic mtDNA ATP6 T8993G mutation was intro-
duced into the PC3 prostate cancer cell line through
cybrid transfer and tested for tumor growth in nude
mice. The resulting mutant (T8993G) cybrids were
found to generate tumors that were 7 times larger than
the wild-type (T8993T) cybrids [24]. The last experi-
ment was by Park JS, they found that the cell line carry-
ing the heteroplasmic ND5 mtDNA mutation showed
significantly enhanced tumor growth. Their results indi-
cate that the mtDNA mutations might play an impor-
tant role in the early stage of cancer development,
possibly through alteration of ROS generation and apop-
tosis [25]. After mutation of mitochondrial genome hap-
pened, I presume mitochondria stop normal oxygen
respiration to hypo-oxygen respiration, the somatic cell
atavism and internal environment of cell changes to be
acid (lactic acid), Which John AP’ hypothesis did image
[26]. Then in the acidic environment the chromosome
genomes transform to disorder then all kinds of malig-
nant characters expressed. In conclusion, I hypothesis
that mutation of mitochondria genome is the trigger of
the normal cell transforming to cancer cells.
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Conclusions
Main conclusions of the Review: (1) Role of mitochon-
dria is important in physiological function of cell. (2)
Probability of mutation of mitochondria genome is
higher than that of human normal cell. (3) Mutation of
mitochondria genome induce alteration of inner envir-
onment in human normal cell. (4) Bad inner environ-
ment results mutation of chromosome genomes and
total cell atavism. (5) Mutation of mitochondria genome:
trigger of normal cell transforming to cancer cell.
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